Moderna shares soar 18% after early coronavirus vaccine trial produces antibodies in all patients (MRNA)

· *Moderna stock surged as much as 18% on Wednesday after the company announced an early coronavirus vaccine trial produced antibodies in all participants.*
· *A range of dosages induced immune responses in all 45 Phase 1 trial patients and was "generally safe and well-tolerated," Moderna said in a press release.*
· *The...